We report herein the development, synthesis, physicochemical and pharmacological characterization of a novel class of pharmacodynamic hybrids that selectively inhibit cyclooxygenase-2 (COX-2) isoform and present suitable nitric oxide releasing properties. The replacement of the ester moiety with the amide group gave access to in vivo more stable and active derivatives that highlighted outstanding pharmacological properties. In particular, the glycine derivative proved to be extremely active in suppressing hyperalgesia and edema.

Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.

CALDERONE, VINCENZO;MARTELLI, ALMA;TESTAI, LARA;
2014

Abstract

We report herein the development, synthesis, physicochemical and pharmacological characterization of a novel class of pharmacodynamic hybrids that selectively inhibit cyclooxygenase-2 (COX-2) isoform and present suitable nitric oxide releasing properties. The replacement of the ester moiety with the amide group gave access to in vivo more stable and active derivatives that highlighted outstanding pharmacological properties. In particular, the glycine derivative proved to be extremely active in suppressing hyperalgesia and edema.
Biava, M; Battilocchio, C; Poce, G; Alfonso, S; Consalvi, S; Di Capua, A; Calderone, Vincenzo; Martelli, Alma; Testai, Lara; Sautebin, L; Rossi, A; Ghelardini, C; Di Cesare Mannelli, L; Giordani, A; Persiani, S; Colovic, M; Dovizio, M; Patrignani, P; Anzini, M.
File in questo prodotto:
File Dimensione Formato  
Bmc Biava et al 2014.pdf

solo utenti autorizzati

Descrizione: Articolo finale
Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.48 MB
Formato Adobe PDF
1.48 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11568/421668
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 22
  • ???jsp.display-item.citation.isi??? 22
social impact